SK

Shanthahally Kumaraswamy Charan Raj

Active Director Designated Partner DIN 11832388
DIN 11832388 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Shanthahally Kumaraswamy Charan Raj

Shanthahally Kumaraswamy Charan Raj is a Designated Partner at Arthus Orthopedics Superspeciality Centre Llp (since 2026).

DIN 11832388
Primary Designation Designated Partner
First Appointment 16 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Jul 20262026Active

Board colleagues of Shanthahally Kumaraswamy Charan Raj

NameDINCompanyDesignation
Neha C Dodamani11832389Arthus Orthopedics Superspeciality Centre LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Arthus Orthopedics Superspeciality Centre Llp
Premium access

Shareholding and investment profile for Shanthahally Kumaraswamy Charan Raj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanthahally Kumaraswamy Charan Raj

Shanthahally Kumaraswamy Charan Raj currently holds 1 directorship: Arthus Orthopedics Superspeciality Centre Llp (Designated Partner, since 16 Jul 2026).

Shanthahally Kumaraswamy Charan Raj was first appointed on 16 Jul 2026 as Designated Partner at Arthus Orthopedics Superspeciality Centre Llp.

The current boards of Shanthahally Kumaraswamy Charan Raj's companies include Neha C Dodamani (Arthus Orthopedics Superspeciality Centre Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available